Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00011180 · ClinicalTrials.gov registry record
Risk Factors for Venous Thromboembolism in the Community
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 385
- Enrollment target
NCT00011180: Completed study, sponsored by Mayo Clinic.
NCT00011180 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 385 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00011180 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 385 participants
- Enrollment target
Study Summary
To evaluate the trends in the incidence of venous thromboembolism, to determine the risk factors for venous thromboembolism in patients with medical and surgical illness, and to evaluate the efficacy of the anticoagulant therapy in reducing venous thromboembolism.
Primary Outcome
The time interval (minutes) was measured retrospectively, using the electronic medical record for each subject.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2001-04 |
| Est. Completion | 2009-05 |
What the finished NCT00011180 record still lists
NCT00011180 is an observational study that tracks outcomes without assigning an intervention. The registered 385 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00011180 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00011180 about?
NCT00011180 is a clinical study titled "Risk Factors for Venous Thromboembolism in the Community". To evaluate the trends in the incidence of venous thromboembolism, to determine the risk factors for venous thromboembolism in patients with medical and surgical illness, and to evaluate the efficacy of the anticoagulant therapy in reducing venous thromboembolism.
What is the current status of trial NCT00011180?
This trial is currently completed. The enrollment target is 385 participants. The study started on 2001-04. Estimated completion is 2009-05.
Who is sponsoring clinical trial NCT00011180?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373823 · 385 participants · NA
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
- NCT05503173 · 385 participants · NA
Telehealth for Pain and Unhealthy Drinking Among PLWH
- NCT06226883 · 385 participants · Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- NCT06290063 · 385 participants · Phase 2
Cannabidiol and Older Adult Cannabis Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia